抗生物膜傷口敷料市場（按機制模式、應用和地區分類）

抗生物膜傷口敷料市場規模預計在 2025 年為 9.456 億美元，預計到 2032 年將達到 22.944 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 13.5%。

抗生物膜敷料產品可用於處理大面積傷口，降低感染風險。使用藻酸鹽或聚合物泡棉抗菌或抑菌敷料處理傷口可防止生物膜再形成。抗生物膜劑可用於預防生物膜形成或防止清創後生物膜再形成，進而促進創傷治療。

市場動態：

慢性病盛行率上升、慢性傷口負擔加重、老年人口增加、外科手術數量增加以及對先進創傷護理產品的需求增加是預測期內推動全球抗生物膜傷口敷料市場成長的關鍵因素。

例如，2021年10月，Imbed Biosciences獲得了美國國家關節炎、肌肉骨骼和皮膚疾病研究所（NIAMS）80萬美元的創傷治療試點（CRP）接受，以支持下一代傷口敷料的後期開發，該敷料可以殺死津貼在傷口生物膜中的細菌並促進傷口癒合。

本研究的主要特點

• 本報告對全球抗生物膜傷口敷料市場進行了詳細分析，並以 2024 年為基準年，提供了 2025 年至 2032 年預測期的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 該報告涵蓋了全球抗生物膜傷口敷料市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球生物膜傷口敷料市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過用於分析全球抗生物膜傷口敷料市場的各種策略矩陣來簡化決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 慢性傷口的盛行率不斷上升
  • 醫療費用高昂
  • 創傷護理產品需求旺盛
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

4. 全球抗生物膜傷口敷料市場-冠狀病毒（COVID-19）大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 2020 年至 2032 年全球抗生物膜傷口敷料市場（以機制模式）

• 身體的
• 化學
• 生物

6. 全球抗生物膜傷口敷料市場（按應用）2020 年至 2032 年

• 急性傷口
• 慢性傷口

7. 2020 年至 2032 年全球抗生物膜傷口敷料市場（按地區）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章 競爭態勢

• 3M
• Convatec Group PLC
• Smith & Nephew PLC
• Urgo Medical
• Coloplast Corporation

第9章 章節

• 調查方法
• 關於出版商

Anti-Biofilm Wound Dressing Market is estimated to be valued at USD 945.6 Mn in 2025 and is expected to reach USD 2,294.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 13.5% from 2025 to 2032.

Anti-biofilm dressing products help manage large wounds, thereby, reducing the risk of infection. Treating wounds with an antimicrobial or bacteriostatic dressing in an alginate or polymeric foam form will help prevent reformation of biofilms. Anti-biofilm agents can be used to prevent biofilm formation or to prevent reformation after debridement, thereby improving the wound healing.

Market Dynamics:

Increasing incidence of chronic diseases, increasing burden of chronic wounds, growing geriatric population, increasing number of surgical procedures, and high demand for advanced wound care products are major factors expected to propel the growth of the global anti-biofilm wound dressing market during the forecast period.

For instance, in October 2021, Imbed Biosciences received US$ 800,000 in a Commercialization Readiness Pilot (CRP) grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS) to support late-stage development of a next-generation wound dressing that can kill bacteria hidden inside the biofilms in wounds and accelerate wound healing.

Key features of the study:

• This report provides in-depth analysis of the global anti-biofilm wound dressing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global anti-biofilm wound dressing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include 3M, Convatec Group PLC, Smith & Nephew PLC, Urgo Medical, and Coloplast Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global anti-biofilm wound dressing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-biofilm wound dressing market.

Detailed Segmentation:

• Global Anti-Biofilm Wound Dressing Market, By Mode of Mechanism:
  • Physical
  • Chemical
  • Biological
• Global Anti-Biofilm Wound Dressing Market, By Application:
  • Acute Wounds
  • Chronic Wounds
• Global Anti-Biofilm Wound Dressing Market, By Geography:
  • North America
  • Latin America Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • 3M
  • Convatec Group PLC
  • Smith & Nephew PLC
  • Urgo Medical
  • Coloplast Corporation

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Mode of Mechanism
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of chronic wounds
  • High cost of treatment
  • High demand for wound care products
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Anti-Biofilm Wound Dressing Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Anti-Biofilm Wound Dressing Market, By Mode of Mechanism, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Physical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Chemical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Biological
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Anti-Biofilm Wound Dressing Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Acute Wounds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Chronic Wounds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Anti-Biofilm Wound Dressing Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Mode of Mechanism, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)

8. Competitive Landscape

• 3M
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Convatec Group PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Smith & Nephew PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Urgo Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Coloplast Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us